# FDA Inspection 1240449 - Amgen, Inc. - February 06, 2024

Source: https://www.keypedia.com/records/fda_inspections/amgen-inc/fe67a98f-c816-4387-bbd9-9d30c82ae96a
Source feed: FDA_Inspections

> FDA Inspection 1240449 for Amgen, Inc. on February 06, 2024. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1240449
- Company Name: Amgen, Inc.
- Inspection Date: 2024-02-06
- Product Type: Human Drugs
- Office Name: Los Angeles District Office

## Related Documents

- [FDA Inspection 1278976 - 2025-08-07](https://www.keypedia.com/records/fda_inspections/amgen-inc/d97d8a62-a229-4000-9007-f563754eede5)
- [FDA Inspection 1278976 - 2025-08-07](https://www.keypedia.com/records/fda_inspections/amgen-inc/41a4234d-3f2f-4bab-ab8b-9a1e17008055)
- [FDA Inspection 1256132 - 2025-03-13](https://www.keypedia.com/records/fda_inspections/amgen-inc/8601b5a4-a27d-4f90-9399-1e0398db8be7)
- [FDA Inspection 1220409 - 2023-09-14](https://www.keypedia.com/records/fda_inspections/amgen-inc/78815a66-7fde-4e3c-b744-48f87db72016)
- [FDA Inspection 1112791 - 2019-12-13](https://www.keypedia.com/records/fda_inspections/amgen-inc/f7c02d35-9f41-4022-9b49-996bf75204ed)

Company: https://www.keypedia.com/companies/amgen-inc/85ec512e-6991-42ee-9cd5-148cfe0ed3e8

Office: https://www.keypedia.com/offices/los-angeles-district-office/edcf1dfe-596a-43b8-8df4-07d9cd94763b